Glaxosmithkline Plc Adr Stock Short Ratio

GSK Stock  USD 43.13  0.14  0.33%   
GlaxoSmithKline PLC ADR fundamentals help investors to digest information that contributes to GlaxoSmithKline PLC's financial success or failures. It also enables traders to predict the movement of GlaxoSmithKline Stock. The fundamental analysis module provides a way to measure GlaxoSmithKline PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GlaxoSmithKline PLC stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

GlaxoSmithKline Short Ratio Analysis

GlaxoSmithKline PLC's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Short Ratio

 = 

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis

Current GlaxoSmithKline PLC Short Ratio

    
  1.01 X  
Most of GlaxoSmithKline PLC's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GlaxoSmithKline PLC ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

GlaxoSmithKline Short Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for GlaxoSmithKline PLC is extremely important. It helps to project a fair market value of GlaxoSmithKline Stock properly, considering its historical fundamentals such as Short Ratio. Since GlaxoSmithKline PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GlaxoSmithKline PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GlaxoSmithKline PLC's interrelated accounts and indicators.
-0.320.50.90.77-0.070.770.970.910.710.70.120.940.120.50.95-0.11-0.160.230.450.56-0.260.57-0.590.590.40.490.5-0.250.2
-0.320.29-0.36-0.590.31-0.3-0.36-0.06-0.380.220.26-0.420.170.11-0.29-0.150.06-0.57-0.03-0.25-0.020.030.11-0.110.26-0.130.050.52-0.7
0.50.290.430.10.390.040.310.480.250.330.880.51-0.10.380.68-0.65-0.230.10.520.690.060.75-0.270.780.70.420.820.35-0.44
0.9-0.360.430.7-0.090.740.890.820.90.650.080.82-0.080.640.84-0.020.020.20.380.5-0.050.47-0.490.650.320.580.5-0.260.24
0.77-0.590.10.7-0.10.780.820.670.590.53-0.230.740.00.350.690.22-0.060.310.260.39-0.150.39-0.510.270.080.130.24-0.220.37
-0.070.310.39-0.09-0.1-0.22-0.090.13-0.090.00.42-0.18-0.14-0.240.03-0.06-0.510.180.580.390.210.54-0.270.110.67-0.190.610.39-0.51
0.77-0.30.040.740.78-0.220.850.80.590.78-0.40.640.290.630.590.410.17-0.130.050.04-0.350.12-0.520.12-0.050.10.06-0.30.38
0.97-0.360.310.890.82-0.090.850.910.750.74-0.110.880.140.470.860.08-0.150.230.410.45-0.270.48-0.630.460.330.420.4-0.290.25
0.91-0.060.480.820.670.130.80.910.650.880.060.720.140.60.790.14-0.04-0.040.440.4-0.20.48-0.540.410.410.310.47-0.210.13
0.71-0.380.250.90.59-0.090.590.750.650.55-0.030.65-0.250.560.660.120.120.250.310.420.140.34-0.310.550.190.530.37-0.180.21
0.70.220.330.650.530.00.780.740.880.55-0.140.490.150.740.550.280.23-0.330.210.1-0.160.25-0.40.180.210.140.21-0.01-0.02
0.120.260.880.08-0.230.42-0.4-0.110.06-0.03-0.140.2-0.220.030.37-0.78-0.290.180.430.630.20.60.020.660.60.320.70.34-0.44
0.94-0.420.510.820.74-0.180.640.880.720.650.490.20.140.380.96-0.33-0.260.40.370.61-0.310.61-0.570.70.350.570.51-0.130.14
0.120.17-0.1-0.080.0-0.140.290.140.14-0.250.15-0.220.14-0.110.020.15-0.29-0.35-0.39-0.45-0.98-0.13-0.17-0.14-0.18-0.09-0.18-0.040.06
0.50.110.380.640.35-0.240.630.470.60.560.740.030.38-0.110.440.130.65-0.46-0.10.020.10.03-0.060.29-0.080.250.12-0.040.13
0.95-0.290.680.840.690.030.590.860.790.660.550.370.960.020.44-0.38-0.260.360.510.73-0.170.73-0.580.760.520.560.67-0.050.03
-0.11-0.15-0.65-0.020.22-0.060.410.080.140.120.28-0.78-0.330.150.13-0.380.38-0.4-0.32-0.59-0.07-0.580.14-0.66-0.53-0.49-0.52-0.370.49
-0.160.06-0.230.02-0.06-0.510.17-0.15-0.040.120.23-0.29-0.26-0.290.65-0.260.38-0.65-0.54-0.460.35-0.640.54-0.34-0.65-0.17-0.56-0.250.39
0.23-0.570.10.20.310.18-0.130.23-0.040.25-0.330.180.4-0.35-0.460.36-0.4-0.650.570.70.210.57-0.420.460.450.350.490.09-0.12
0.45-0.030.520.380.260.580.050.410.440.310.210.430.37-0.39-0.10.51-0.32-0.540.570.840.340.75-0.540.430.870.150.720.07-0.31
0.56-0.250.690.50.390.390.040.450.40.420.10.630.61-0.450.020.73-0.59-0.460.70.840.330.85-0.410.720.770.40.810.11-0.23
-0.26-0.020.06-0.05-0.150.21-0.35-0.27-0.20.14-0.160.2-0.31-0.980.1-0.17-0.070.350.210.340.330.040.240.010.15-0.040.120.1-0.13
0.570.030.750.470.390.540.120.480.480.340.250.60.61-0.130.030.73-0.58-0.640.570.750.850.04-0.650.760.880.450.920.41-0.52
-0.590.11-0.27-0.49-0.51-0.27-0.52-0.63-0.54-0.31-0.40.02-0.57-0.17-0.06-0.580.140.54-0.42-0.54-0.410.24-0.65-0.4-0.56-0.25-0.53-0.160.24
0.59-0.110.780.650.270.110.120.460.410.550.180.660.7-0.140.290.76-0.66-0.340.460.430.720.010.76-0.40.60.810.830.25-0.29
0.40.260.70.320.080.67-0.050.330.410.190.210.60.35-0.18-0.080.52-0.53-0.650.450.870.770.150.88-0.560.60.360.870.31-0.59
0.49-0.130.420.580.13-0.190.10.420.310.530.140.320.57-0.090.250.56-0.49-0.170.350.150.4-0.040.45-0.250.810.360.52-0.01-0.1
0.50.050.820.50.240.610.060.40.470.370.210.70.51-0.180.120.67-0.52-0.560.490.720.810.120.92-0.530.830.870.520.36-0.47
-0.250.520.35-0.26-0.220.39-0.3-0.29-0.21-0.18-0.010.34-0.13-0.04-0.04-0.05-0.37-0.250.090.070.110.10.41-0.160.250.31-0.010.36-0.9
0.2-0.7-0.440.240.37-0.510.380.250.130.21-0.02-0.440.140.060.130.030.490.39-0.12-0.31-0.23-0.13-0.520.24-0.29-0.59-0.1-0.47-0.9
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition

GlaxoSmithKline Discontinued Operations

Discontinued Operations

12.67 Billion

At this time, GlaxoSmithKline PLC's Discontinued Operations is quite stable compared to the past year.
Based on the latest financial disclosure, GlaxoSmithKline PLC ADR has a Short Ratio of 1.01 times. This is 74.1% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The short ratio for all United States stocks is 74.75% higher than that of the company.

GlaxoSmithKline Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GlaxoSmithKline PLC's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GlaxoSmithKline PLC could also be used in its relative valuation, which is a method of valuing GlaxoSmithKline PLC by comparing valuation metrics of similar companies.
GlaxoSmithKline PLC is currently under evaluation in short ratio category among related companies.

GlaxoSmithKline PLC Institutional Holders

Institutional Holdings refers to the ownership stake in GlaxoSmithKline PLC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of GlaxoSmithKline PLC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing GlaxoSmithKline PLC's value.
Shares
Arrowstreet Capital Limited Partnership2023-12-31
4.8 M
Deutsche Bank Ag2023-09-30
4.4 M
Provident Trust Company2023-12-31
3.7 M
Equity Investment Corp2023-12-31
3.2 M
Eversept Partners, Llc2023-12-31
M
Camber Capital Management Llc2023-09-30
2.9 M
Hotchkis & Wiley Capital Management Llc2023-09-30
2.8 M
Renaissance Technologies Corp2023-12-31
2.8 M
Millennium Management Llc2023-09-30
2.6 M
Dodge & Cox2023-12-31
69 M
Fmr Inc2023-09-30
18.1 M

GlaxoSmithKline Fundamentals

About GlaxoSmithKline PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze GlaxoSmithKline PLC ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GlaxoSmithKline PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GlaxoSmithKline PLC ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Gsk Plc is traded on New York Stock Exchange in the United States.

GlaxoSmithKline PLC Investors Sentiment

The influence of GlaxoSmithKline PLC's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in GlaxoSmithKline. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to GlaxoSmithKline PLC's public news can be used to forecast risks associated with an investment in GlaxoSmithKline. The trend in average sentiment can be used to explain how an investor holding GlaxoSmithKline can time the market purely based on public headlines and social activities around GlaxoSmithKline PLC ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
GlaxoSmithKline PLC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for GlaxoSmithKline PLC's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average GlaxoSmithKline PLC's news discussions. The higher the estimated score, the more favorable is the investor's outlook on GlaxoSmithKline PLC.

GlaxoSmithKline PLC Implied Volatility

    
  20.49  
GlaxoSmithKline PLC's implied volatility exposes the market's sentiment of GlaxoSmithKline PLC ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if GlaxoSmithKline PLC's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that GlaxoSmithKline PLC stock will not fluctuate a lot when GlaxoSmithKline PLC's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GlaxoSmithKline PLC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GlaxoSmithKline PLC's short interest history, or implied volatility extrapolated from GlaxoSmithKline PLC options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out GlaxoSmithKline PLC Piotroski F Score and GlaxoSmithKline PLC Altman Z Score analysis.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bonds Directory
Find actively traded corporate debentures issued by US companies
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
3.02
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.